About the Authors
- Takuya Kuroda
-
Affiliations Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo, Japan, Foundation for Biomedical Research and Innovation, Kobe, Japan
- Satoshi Yasuda
-
Affiliation Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo, Japan
- Shinji Kusakawa
-
Affiliations Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo, Japan, Foundation for Biomedical Research and Innovation, Kobe, Japan
- Naoya Hirata
-
Affiliation Division of Pharmacology, National Institute of Health Sciences, Tokyo, Japan
- Yasunari Kanda
-
Affiliation Division of Pharmacology, National Institute of Health Sciences, Tokyo, Japan
- Kazuhiro Suzuki
-
Affiliation Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo, Japan
- Masayo Takahashi
-
Affiliations Foundation for Biomedical Research and Innovation, Kobe, Japan, Laboratory for Retinal Regeneration, RIKEN Center for Developmental Biology, Kobe, Japan
- Shin-Ichi Nishikawa
-
Affiliations Foundation for Biomedical Research and Innovation, Kobe, Japan, Laboratory of Stem Cell Research, RIKEN Center for Developmental Biology, Kobe, Japan
- Shin Kawamata
-
Affiliation Foundation for Biomedical Research and Innovation, Kobe, Japan
- Yoji Sato
-
* E-mail: yoji@nihs.go.jp
Affiliations Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo, Japan, Foundation for Biomedical Research and Innovation, Kobe, Japan, Department of Pharmaceutical Quality Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: TK SY YS. Performed the experiments: TK SY NH. Analyzed the data: TK SY S. Kusakawa NH YK KS MT SN S. Kawamata YS. Contributed reagents/materials/analysis tools: YK MT S. Kawamata. Wrote the paper: TK SY YS. Acquired the funding: SN S. Kawamata KS YS.